Ainos Reports Unaudited Third Quarter 2022 Financial Results
- Written by PR Newswire
Revenues increased by 384% year over year
Debt ratio decreased to 7% from 75% at year-end 2021
SAN DIEGO, Nov. 7, 2022 /PRNewswire/ -- Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified medtech company focused on the development of novel point-of-care testing, low-dose interferon therapeutics, and synthetic RNA-driven...
